News
CSPCY
4.590
NaN%
--
Weekly Report: what happened at CSPCY last week (0323-0327)?
Weekly Report · 6d ago
Weekly Report: what happened at CSPCY last week (0316-0320)?
Weekly Report · 03/23 10:30
Weekly Report: what happened at CSPCY last week (0309-0313)?
Weekly Report · 03/16 10:29
Weekly Report: what happened at CSPCY last week (0302-0306)?
Weekly Report · 03/09 10:30
Weekly Report: what happened at CSPCY last week (0223-0227)?
Weekly Report · 03/02 10:29
Weekly Report: what happened at CSPCY last week (0216-0220)?
Weekly Report · 02/23 10:29
China drug licensing deals surge nearly 10-fold in value since 2021
Seeking Alpha · 02/19 18:31
Weekly Report: what happened at CSPCY last week (0209-0213)?
Weekly Report · 02/16 10:29
AstraZeneca rises as cancer drugs power Q4 beat
Seeking Alpha · 02/10 12:39
Weekly Report: what happened at CSPCY last week (0202-0206)?
Weekly Report · 02/09 10:30
Weekly Report: what happened at CSPCY last week (0126-0130)?
Weekly Report · 02/02 10:30
Weekly Report: what happened at CSPCY last week (0119-0123)?
Weekly Report · 01/26 10:30
Weekly Report: what happened at CSPCY last week (0112-0116)?
Weekly Report · 01/19 10:37
Weekly Report: what happened at CSPCY last week (0105-0109)?
Weekly Report · 01/12 10:36
I Expect Novo Nordisk To Outperform Eli Lilly In 2026: Here's Why
Seeking Alpha · 01/05 14:53
Weekly Report: what happened at CSPCY last week (1229-0102)?
Weekly Report · 01/05 10:29
Notable healthcare headlines for the week: UnitedHealth, Molina Healthcare, and Novo Nordisk in focus
Seeking Alpha · 01/04 14:05
Eli Lilly, Novo waging price wars as obesity drug market heats up in China
Seeking Alpha · 12/30/2025 12:43
Weekly Report: what happened at CSPCY last week (1222-1226)?
Weekly Report · 12/29/2025 10:28
Weekly Report: what happened at CSPCY last week (1215-1219)?
Weekly Report · 12/22/2025 10:28
More
Webull provides a variety of real-time CSPCY stock news. You can receive the latest news about Cspc Pharmaceuti through multiple platforms. This information may help you make smarter investment decisions.
About CSPCY
CSPC Pharmaceutical Group Ltd is an investment holding company primarily engaged in the manufacture and sale of pharmaceutical products. The Company operates its business through three segments. The Finished Drugs segment in engaged in the research and development, manufacture and sale of pharmaceutical products and licensing business. The Bulk Products segment is engaged in the manufacture and sale of vitamin C, and antibiotic products in bulk powder form. The Functional Food and Others segment is engaged in the manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. The Company’s product therapeutic areas include nervous system, oncology, anti-infectives, cardiovascular, respiratory system, digestion and metabolism and others. The Company conducts its business in the domestic and overseas markets.